According to Zacks, “HeidelbergCement AG operates as a building materials manufacturer. It engages in the production and distribution of cement and aggregates. The Company also offers ready-mixed concrete, concrete products, and concrete elements, as well as other related products and services. It has operations in sub-Saharan Africa: Benin, DR Congo, Gabon, Ghana, Liberia, Sierra Leone, Tanzania, and Togo. HeidelbergCement AG is headquartered in Heidelberg, Germany. “
Several other equities research analysts have also weighed in on the company. Berenberg Bank reissued a “sell” rating and set a GBX 65 ($0.85) target price on shares of AA in a research report on Thursday, April 4th. Kepler Capital Markets reissued a “hold” rating on shares of HEIDELBERGCEMEN/ADR in a research report on Tuesday, July 9th. Societe Generale reissued a “sell” rating on shares of HEIDELBERGCEMEN/ADR in a research report on Monday, May 20th. Barclays reissued an “underweight” rating and set a GBX 600 ($7.84) target price on shares of in a research report on Monday, July 8th. Finally, ValuEngine lowered Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $17.00.
HEIDELBERGCEMEN/ADR Company Profile
HeidelbergCement AG produces and distributes cement, aggregates, ready-mixed concrete, and asphalt worldwide. The company offers cement products, including special cements with targeted characteristics, special geotechnical building materials, and a range of binders. It also provides natural stone aggregates, comprising sand and gravel; crushed aggregates, such as stone chippings and crushed stones; and concrete/ready-mixed concrete for the production of precast concrete parts consisting of stairs, ceiling elements, or structural components, as well as for use in the construction of tunnels or bridges, office buildings, or schools.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HEIDELBERGCEMEN/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEIDELBERGCEMEN/ADR and related companies with MarketBeat.com's FREE daily email newsletter.